New drugs, fair prices: managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines
"New Drugs, Fair Prices addresses the important question of how we might get the innovative new medicines we need at prices we can afford. Today, this debate is impassioned but sterile. One side calls for price controls, discounting their impact on investment in innovation. The other points to...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Weitere Verfasser: | |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
London ; New York
Routledge
2023
|
| Schlagworte: | |
| Online-Zugang: | UPA01 Volltext |
| Zusammenfassung: | "New Drugs, Fair Prices addresses the important question of how we might get the innovative new medicines we need at prices we can afford. Today, this debate is impassioned but sterile. One side calls for price controls, discounting their impact on investment in innovation. The other points to miraculous new therapies, disregarding their affordability and social inequity. This polarized argument creates more heat than light, threatening the social contract between the industry and society on which we pharmaceutical innovation depends. This ground-breaking book takes a wholly new perspective on the issue and raises the debate to a more informed and productive level. Drawing on interviews with more than 70 experts across the pharmaceutical innovation world and combining a diverse literature from scientific, political, economic and business domains, it describes how a sustainable and affordable supply of new medicines is possible only by balancing pharmaceutical innovation's complex, adaptive ecosystem. By considering how each of the ecosystem's seven habitats work and interact with each other, it makes a comprehensive set of recommendations for achieving that ecosystem balance. The core message of New Drugs, Fair Prices is important to anyone who ever has needed or will ever need a medicine: we can have a sustainable supply of new medicines that are both innovative and affordable if we manage the pharmaceutical innovation ecosystem intelligently"-- |
| Beschreibung: | 1 Online-Ressource (xv, 306 seiten) Illustrationen |
| ISBN: | 9781003330271 |
| DOI: | 10.4324/9781003330271 |
Internformat
MARC
| LEADER | 00000nmm a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV048905446 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 230419s2023 xxk|||| o||u| ||||||eng d | ||
| 020 | |a 9781003330271 |c Online |9 9781003330271 | ||
| 024 | 7 | |a 10.4324/9781003330271 |2 doi | |
| 035 | |a (OCoLC)1378501997 | ||
| 035 | |a (DE-599)BVBBV048905446 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a xxk |c XA-GB | ||
| 049 | |a DE-739 | ||
| 082 | 0 | |a 338.4/361510973 | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 084 | |a QX 700 |0 (DE-625)142186: |2 rvk | ||
| 084 | |a 83.79 |2 bkl | ||
| 100 | 1 | |a Smith, Brian D. |d 1961- |e Verfasser |0 (DE-588)1167817079 |4 aut | |
| 245 | 1 | 0 | |a New drugs, fair prices |b managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines |c Brian D. Smith ; edited by Lindsay Bruce Smith |
| 264 | 1 | |a London ; New York |b Routledge |c 2023 | |
| 300 | |a 1 Online-Ressource (xv, 306 seiten) |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | 3 | |a "New Drugs, Fair Prices addresses the important question of how we might get the innovative new medicines we need at prices we can afford. Today, this debate is impassioned but sterile. One side calls for price controls, discounting their impact on investment in innovation. The other points to miraculous new therapies, disregarding their affordability and social inequity. This polarized argument creates more heat than light, threatening the social contract between the industry and society on which we pharmaceutical innovation depends. This ground-breaking book takes a wholly new perspective on the issue and raises the debate to a more informed and productive level. Drawing on interviews with more than 70 experts across the pharmaceutical innovation world and combining a diverse literature from scientific, political, economic and business domains, it describes how a sustainable and affordable supply of new medicines is possible only by balancing pharmaceutical innovation's complex, adaptive ecosystem. By considering how each of the ecosystem's seven habitats work and interact with each other, it makes a comprehensive set of recommendations for achieving that ecosystem balance. The core message of New Drugs, Fair Prices is important to anyone who ever has needed or will ever need a medicine: we can have a sustainable supply of new medicines that are both innovative and affordable if we manage the pharmaceutical innovation ecosystem intelligently"-- | |
| 650 | 0 | 7 | |a Innovationsmanagement |0 (DE-588)4161817-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kostenoptimierung |0 (DE-588)4135132-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 653 | 0 | |a Drugs / Prices / United States | |
| 653 | 0 | |a Prescription pricing / United States | |
| 653 | 0 | |a Pharmaceutical industry / United States | |
| 653 | 0 | |a Drugs / United States / Cost control | |
| 689 | 0 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | 1 | |a Innovationsmanagement |0 (DE-588)4161817-8 |D s |
| 689 | 0 | 2 | |a Kostenoptimierung |0 (DE-588)4135132-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Smith, Lindsay Bruce |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 978-1-03-236105-5 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-1-03-235223-7 |
| 856 | 4 | 0 | |u https://doi.org/10.4324/9781003330271 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-7-HUS | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034169739 | ||
| 966 | e | |u https://doi.org/10.4324/9781003330271 |l UPA01 |p ZDB-7-HUS |q UPA_PDA_HUS_Kauf2022 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804185072762355712 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Smith, Brian D. 1961- |
| author2 | Smith, Lindsay Bruce |
| author2_role | edt |
| author2_variant | l b s lb lbs |
| author_GND | (DE-588)1167817079 |
| author_facet | Smith, Brian D. 1961- Smith, Lindsay Bruce |
| author_role | aut |
| author_sort | Smith, Brian D. 1961- |
| author_variant | b d s bd bds |
| building | Verbundindex |
| bvnumber | BV048905446 |
| classification_rvk | QR 525 QX 700 |
| collection | ZDB-7-HUS |
| ctrlnum | (OCoLC)1378501997 (DE-599)BVBBV048905446 |
| dewey-full | 338.4/361510973 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/361510973 |
| dewey-search | 338.4/361510973 |
| dewey-sort | 3338.4 9361510973 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| doi_str_mv | 10.4324/9781003330271 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03673nmm a2200541 c 4500</leader><controlfield tag="001">BV048905446</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230419s2023 xxk|||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781003330271</subfield><subfield code="c">Online</subfield><subfield code="9">9781003330271</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.4324/9781003330271</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1378501997</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048905446</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxk</subfield><subfield code="c">XA-GB</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-739</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/361510973</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QX 700</subfield><subfield code="0">(DE-625)142186:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">83.79</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Smith, Brian D.</subfield><subfield code="d">1961-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1167817079</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New drugs, fair prices</subfield><subfield code="b">managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines</subfield><subfield code="c">Brian D. Smith ; edited by Lindsay Bruce Smith</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London ; New York</subfield><subfield code="b">Routledge</subfield><subfield code="c">2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xv, 306 seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"New Drugs, Fair Prices addresses the important question of how we might get the innovative new medicines we need at prices we can afford. Today, this debate is impassioned but sterile. One side calls for price controls, discounting their impact on investment in innovation. The other points to miraculous new therapies, disregarding their affordability and social inequity. This polarized argument creates more heat than light, threatening the social contract between the industry and society on which we pharmaceutical innovation depends. This ground-breaking book takes a wholly new perspective on the issue and raises the debate to a more informed and productive level. Drawing on interviews with more than 70 experts across the pharmaceutical innovation world and combining a diverse literature from scientific, political, economic and business domains, it describes how a sustainable and affordable supply of new medicines is possible only by balancing pharmaceutical innovation's complex, adaptive ecosystem. By considering how each of the ecosystem's seven habitats work and interact with each other, it makes a comprehensive set of recommendations for achieving that ecosystem balance. The core message of New Drugs, Fair Prices is important to anyone who ever has needed or will ever need a medicine: we can have a sustainable supply of new medicines that are both innovative and affordable if we manage the pharmaceutical innovation ecosystem intelligently"--</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Innovationsmanagement</subfield><subfield code="0">(DE-588)4161817-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kostenoptimierung</subfield><subfield code="0">(DE-588)4135132-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drugs / Prices / United States</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Prescription pricing / United States</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry / United States</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drugs / United States / Cost control</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Innovationsmanagement</subfield><subfield code="0">(DE-588)4161817-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Kostenoptimierung</subfield><subfield code="0">(DE-588)4135132-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Smith, Lindsay Bruce</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">978-1-03-236105-5</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-1-03-235223-7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.4324/9781003330271</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-7-HUS</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034169739</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.4324/9781003330271</subfield><subfield code="l">UPA01</subfield><subfield code="p">ZDB-7-HUS</subfield><subfield code="q">UPA_PDA_HUS_Kauf2022</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV048905446 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T21:52:05Z |
| indexdate | 2024-07-10T09:49:25Z |
| institution | BVB |
| isbn | 9781003330271 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034169739 |
| oclc_num | 1378501997 |
| open_access_boolean | |
| owner | DE-739 |
| owner_facet | DE-739 |
| physical | 1 Online-Ressource (xv, 306 seiten) Illustrationen |
| psigel | ZDB-7-HUS ZDB-7-HUS UPA_PDA_HUS_Kauf2022 |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | Routledge |
| record_format | marc |
| spelling | Smith, Brian D. 1961- Verfasser (DE-588)1167817079 aut New drugs, fair prices managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines Brian D. Smith ; edited by Lindsay Bruce Smith London ; New York Routledge 2023 1 Online-Ressource (xv, 306 seiten) Illustrationen txt rdacontent c rdamedia cr rdacarrier "New Drugs, Fair Prices addresses the important question of how we might get the innovative new medicines we need at prices we can afford. Today, this debate is impassioned but sterile. One side calls for price controls, discounting their impact on investment in innovation. The other points to miraculous new therapies, disregarding their affordability and social inequity. This polarized argument creates more heat than light, threatening the social contract between the industry and society on which we pharmaceutical innovation depends. This ground-breaking book takes a wholly new perspective on the issue and raises the debate to a more informed and productive level. Drawing on interviews with more than 70 experts across the pharmaceutical innovation world and combining a diverse literature from scientific, political, economic and business domains, it describes how a sustainable and affordable supply of new medicines is possible only by balancing pharmaceutical innovation's complex, adaptive ecosystem. By considering how each of the ecosystem's seven habitats work and interact with each other, it makes a comprehensive set of recommendations for achieving that ecosystem balance. The core message of New Drugs, Fair Prices is important to anyone who ever has needed or will ever need a medicine: we can have a sustainable supply of new medicines that are both innovative and affordable if we manage the pharmaceutical innovation ecosystem intelligently"-- Innovationsmanagement (DE-588)4161817-8 gnd rswk-swf Kostenoptimierung (DE-588)4135132-0 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Drugs / Prices / United States Prescription pricing / United States Pharmaceutical industry / United States Drugs / United States / Cost control Arzneimittelentwicklung (DE-588)4143176-5 s Innovationsmanagement (DE-588)4161817-8 s Kostenoptimierung (DE-588)4135132-0 s DE-604 Smith, Lindsay Bruce edt Erscheint auch als Druck-Ausgabe, Paperback 978-1-03-236105-5 Erscheint auch als Druck-Ausgabe, Hardcover 978-1-03-235223-7 https://doi.org/10.4324/9781003330271 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Smith, Brian D. 1961- New drugs, fair prices managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines Innovationsmanagement (DE-588)4161817-8 gnd Kostenoptimierung (DE-588)4135132-0 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| subject_GND | (DE-588)4161817-8 (DE-588)4135132-0 (DE-588)4143176-5 |
| title | New drugs, fair prices managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines |
| title_auth | New drugs, fair prices managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines |
| title_exact_search | New drugs, fair prices managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines |
| title_exact_search_txtP | New drugs, fair prices managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines |
| title_full | New drugs, fair prices managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines Brian D. Smith ; edited by Lindsay Bruce Smith |
| title_fullStr | New drugs, fair prices managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines Brian D. Smith ; edited by Lindsay Bruce Smith |
| title_full_unstemmed | New drugs, fair prices managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines Brian D. Smith ; edited by Lindsay Bruce Smith |
| title_short | New drugs, fair prices |
| title_sort | new drugs fair prices managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines |
| title_sub | managing the pharmaceutical innovation ecosystem for sustainable and affordable new medicines |
| topic | Innovationsmanagement (DE-588)4161817-8 gnd Kostenoptimierung (DE-588)4135132-0 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| topic_facet | Innovationsmanagement Kostenoptimierung Arzneimittelentwicklung |
| url | https://doi.org/10.4324/9781003330271 |
| work_keys_str_mv | AT smithbriand newdrugsfairpricesmanagingthepharmaceuticalinnovationecosystemforsustainableandaffordablenewmedicines AT smithlindsaybruce newdrugsfairpricesmanagingthepharmaceuticalinnovationecosystemforsustainableandaffordablenewmedicines |